ARCHIVES

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

This article is from The Cancer Letter archive.

Vol. 24 No. 01 | January 9, 1998

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

Funding Opportunities

October 11, 2002

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate?

December 19, 2014

Burton’s Clinic Reopens; Some Insurers Reportedly Reimbursing; New York Congressman Calls For Evaluation

March 28, 1986